Sensorion S.A.
SENOF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.59B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.59 Billion |
|---|---|
| Enterprise Value | $18.20 Billion |
| Earnings per Share | $-1.49 |
| Beta | 0 |
| Outstanding Shares | 1,683,338,237 |
Return
| Return on Equity | -13.59% |
|---|---|
| Return on Assets | -3.54% |
| Return on Invested Capital | 4.03% |
Valuation & Multiples
| P/E Ratio | -1.98 |
|---|---|
| PEG | 1.09 |
| Price to Sales | 0.09 |
| Price to Book Ratio | 0.3 |
| Enterprise Value to Revenue | 0.34 |
| Enterprise Value to EBIT | 11.93 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 1.26 |
| Debt to Equity | 1.53 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Sensorion S.A.
66 employees
CEO: Frédéric Chéreau
Sensorion SA is a clinical-stage biopharmaceutical firm based in Montpellier, France, specializing in the development of therapies for inner ear disorders. Their key initiatives include gene therapy programs: OTOF-GT, designed to restore...